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INCIDENCE OF THYROID CANCER?
Venkat M. Reddy 1, Andrew Lau 1, Tarig Abdelrahman 1, Andrew J.
Carswell 2. 1 Royal Cornwall Hospital NHS Trust; 2University Hospitals
Bristol NHS Trust
Introduction: Radon is a naturally occurring radioactive gas which is
present in rocks and soils. High levels of radon exposure is known to
increase the risk of lung cancer. Radon exposure has been implicated in
thyroid cancer although there is little evidence to support this. The aim of
this study is to investigate whether there is an association between the
incidence of thyroid cancer and radon levels.
Method: Age standardised incidence rates for thyroid cancer were
calculated for each Strategic Health Authority (SHA) in England based on
National Cancer Registry data from 1990-2006 and population estimates
from the Ofﬁce for National Statistics. Indicators of radon levels for the
SHAs were calculated based on radon data from the Health Protection
Agency.
Results: Spearman's rank correlation did not identify any signiﬁcant
correlation between age standardised incidence rates for thyroid cancer
and indicators of radon levels (number of properties at or above action
level in SHA rho ¼ 0.06, p ¼ 0.88; percentage of dwellings measured
rho ¼ 0.103, p ¼ 0.78; highest radon level recorded rho ¼ 0.164,
p ¼ 0.651).
Conclusion: There is no signiﬁcant association between radon exposure
and incidence of thyroid cancer on the basis of the data analysed in this
study.PLATELET DERIVED CD154 MEDIATES HUMAN HEPATOCYTE DEATH
DURING ISCHAEMIA-REPERFUSION INJURY
R.H. Bhogal, D.H. Adams, S.C. Afford. University of Birmingham
Background: During liver transplantation, hepatocytes are exposed to
periods of hypoxia and reoxygenation, as a consequence of ischemia-
reperfusion injury (IRI). Reactive Oxygen Species (ROS) modulate hepa-
tocyte death during IRI. Activation of hepatocyte CD40, a Tumour Necrosis
Factor Receptor super-family member, by it's ligand CD154 is known to
effect allograft rejection. Whether CD40 activation can result in ROS
accumulation and human hepatocyte injury is not known. Hypothesis:
Hypoxia and reoxygenation drive hepatocyte ROS production which
sensitise cells to CD40 mediated apoptosis.
Methods: Human hepatocytes were isolated from liver tissue and
exposed to hypoxia and reoxygenation in the presence or absence of
recombinant or platelet derived CD154. ROS production, apoptosis and
necrosis were determined by labelling cells with 2',7'-dichloro-
ﬂuorescin, Annexin-V and 7-AAD respectively followed by ﬂow
cytometry.
Results: Hepatocytes increased ROS accumulation during hypoxia and
reoxygenation resulting in increased necro-apoptosis. Co-incubation of
hepatocytes with CD154 augmented ROS accumulation during hypoxia
and reoxygenation enhancing necro-apoptosis. Activated platelets secrete
CD154 which also mediated hepatocyte injury during hypoxia and
reoxygenation.
Conclusions: CD40 activation by platelet-derived CD154, increases ROS
production enhancing human hepatocyte injury during IRI. This novel
ﬁnding suggests that inhibition of CD154-stimulated ROS provides
a potential avenue to limit liver damage following transplantation.LEFT INTERNAL MAMMARY ARTERY IN CORONARY ARTERY BYPASS
GRAFTING AND JUSTIFICATION FOR NON-USE
N.A. Hirst, R.W. White. Cardiothoracic Unit, Leeds General Inﬁrmary,
Yorkshire, UK
Left internal mammary artery (LIMA) is currently considered the conduit
of choice to the left anterior descending artery (LAD) in surgical revas-
cularisation. It is proven to offer better long-term patency and patient
survival compared with saphenous vein grafts (SVG). We analysed all
patients having surgical revascularisation over a 12-month period,
establishing rate of LIMA usage, and rationale for non-use. Of 780
patients, 562 (72%) received LIMA to LAD. Of the 706 LADs grafted, 562
(78.6%) were with LIMA, 3 with other arterial conduit, and 141 SVG.
Reasons established for not using LIMA were: small LAD (LIMA grafted to
alternative vessel), poor quality LIMA, emergency surgery, obesity,
concurrent valve surgery, and signiﬁcant pulmonary disease. However,
reasons were not stated in 93 of 126 operation notes (74%). LIMA usage
varied from 60% to 95% between surgeons. Low cardiac output, renal
failure, atrial ﬁbrillation, transfusion rate, hospital stay and mortality
were lower in the LIMA group. Re-exploration rate and sternal compli-
cations were higher in the LIMA group. LIMA to LAD should be the goal
for surgical revascularisation, accepting that there may be contra-indi-
cations to use. Reasons for non-use should be recorded, if to be used as
a quality indicator.A NOVEL NANOCOMPOSITE POLYMER AS A POTENTIAL SCAFFOLD IN
ATTEMPTS TO TISSUE ENGINEER SMALL INTESTINE
Najib Daulatzai, Arnold Darbyshire, Marilena Loizidou, Alexander
Seifalian, Marc Winslet. Academic Department of Surgery, University
College London Medical School, Royal Free Hospital campus
Introduction: Tissue engineering offers an exciting alternative approach
to the management of short bowel syndrome.
Aims: To evaluate mechanical properties and the in-vitro cell growth of
rat intestinal stem cells on a novel, POSS-PCL polymer.
Methods: Cells were seeded onto POSS-PCL discs and plastic wells in 24
well plates. ABF as a marker of cell growth was measured at days 7, 14 and
21. Toxicity was assessed using an LDH assay from sampled supernatant.
Tensile strength properties were calculated using an Instron tensometer
and viscosity using a Bohlin rheometer.
Results: ABF was substantially increased at day 21 post seeding compared
to day 14 and 7 (55.9 AFU vs. 15.6 AFU vs. 10.59 AFU, p < 0.001). LDH
concentrations in POSS-PCL supernatants were comparably lower to
plastic in all subgroups (Day 21; 0.78 u/ml vs. 2.64 u/ml, p < 0.001).
Polymer viscosity was13 PaS and stress at break at 958%.
Conclusions: The use of POSS-PCL polymer as a scaffold for tissue engi-
neering small bowel is promising. The polymer shows minimal cellular
toxicity and good tensile strength whilst acting as a framework that can
sustain cellular growth and proliferation. POSS-PCL; Polyhydrel Oligomeric
Silsesquixane modiﬁed Polycaprolactone ABF; Alamar Blue Fluorescence
LDH: Lactate Dehydrogenase AFU; Arbitrary Fluorescent unitsTOUCH IMPRINT CYTOLOGY OF AXILLARY LYMPH NODES IN A DISTRICT
GENERAL HOSPITAL SETTING: A FEASIBILITY STUDY
S.L. Horn, E.F. Shah. 1Guy's Hospital, London; 2 Conquest Hospital,
Hastings
